Logo image of JEN.DE

JENOPTIK AG (JEN.DE) Stock Fundamental Analysis

Europe - FRA:JEN - DE000A2NB601 - Common Stock

19.31 EUR
-0.41 (-2.08%)
Last: 10/14/2025, 5:35:30 PM
Fundamental Rating

5

JEN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Electronic Equipment, Instruments & Components industry. JEN has only an average score on both its financial health and profitability. JEN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year JEN was profitable.
JEN had a positive operating cash flow in the past year.
Each year in the past 5 years JEN has been profitable.
In the past 5 years JEN always reported a positive cash flow from operatings.
JEN.DE Yearly Net Income VS EBIT VS OCF VS FCFJEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

JEN has a better Return On Assets (4.67%) than 76.36% of its industry peers.
Looking at the Return On Equity, with a value of 8.08%, JEN is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
JEN has a better Return On Invested Capital (6.34%) than 72.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JEN is below the industry average of 10.49%.
Industry RankSector Rank
ROA 4.67%
ROE 8.08%
ROIC 6.34%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
JEN.DE Yearly ROA, ROE, ROICJEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

JEN's Profit Margin of 7.21% is amongst the best of the industry. JEN outperforms 83.64% of its industry peers.
In the last couple of years the Profit Margin of JEN has remained more or less at the same level.
With an excellent Operating Margin value of 11.41%, JEN belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.
In the last couple of years the Operating Margin of JEN has grown nicely.
JEN has a worse Gross Margin (32.28%) than 67.27% of its industry peers.
In the last couple of years the Gross Margin of JEN has remained more or less at the same level.
Industry RankSector Rank
OM 11.41%
PM (TTM) 7.21%
GM 32.28%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
JEN.DE Yearly Profit, Operating, Gross MarginsJEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JEN is still creating some value.
JEN has about the same amout of shares outstanding than it did 1 year ago.
JEN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, JEN has an improved debt to assets ratio.
JEN.DE Yearly Shares OutstandingJEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JEN.DE Yearly Total Debt VS Total AssetsJEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

JEN has an Altman-Z score of 2.53. This is not the best score and indicates that JEN is in the grey zone with still only limited risk for bankruptcy at the moment.
JEN has a Altman-Z score (2.53) which is in line with its industry peers.
JEN has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as JEN would need 6.46 years to pay back of all of its debts.
JEN has a Debt to FCF ratio (6.46) which is in line with its industry peers.
JEN has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
JEN has a Debt to Equity ratio (0.33) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 6.46
Altman-Z 2.53
ROIC/WACC1.09
WACC5.81%
JEN.DE Yearly LT Debt VS Equity VS FCFJEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

JEN has a Current Ratio of 1.62. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Current ratio (1.62) which is comparable to the rest of the industry.
JEN has a Quick Ratio of 1.62. This is a bad value and indicates that JEN is not financially healthy enough and could expect problems in meeting its short term obligations.
JEN has a worse Quick ratio (0.80) than 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.8
JEN.DE Yearly Current Assets VS Current LiabilitesJEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for JEN have decreased by -3.57% in the last year.
The Earnings Per Share has been growing slightly by 6.54% on average over the past years.
JEN shows a decrease in Revenue. In the last year, the revenue decreased by -2.59%.
JEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.46% yearly.
EPS 1Y (TTM)-3.57%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-2.59%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-10.49%

3.2 Future

JEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.69% yearly.
Based on estimates for the next years, JEN will show a small growth in Revenue. The Revenue will grow by 3.76% on average per year.
EPS Next Y-16.22%
EPS Next 2Y3.11%
EPS Next 3Y6.91%
EPS Next 5Y9.69%
Revenue Next Year-4.34%
Revenue Next 2Y0.79%
Revenue Next 3Y2.53%
Revenue Next 5Y3.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JEN.DE Yearly Revenue VS EstimatesJEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
JEN.DE Yearly EPS VS EstimatesJEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

JEN is valuated correctly with a Price/Earnings ratio of 14.30.
JEN's Price/Earnings ratio is rather cheap when compared to the industry. JEN is cheaper than 85.45% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.34. JEN is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 11.21, the valuation of JEN can be described as reasonable.
72.73% of the companies in the same industry are more expensive than JEN, based on the Price/Forward Earnings ratio.
JEN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.3
Fwd PE 11.21
JEN.DE Price Earnings VS Forward Price EarningsJEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JEN is valued a bit cheaper than 67.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, JEN is valued a bit cheaper than the industry average as 61.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.05
EV/EBITDA 7.57
JEN.DE Per share dataJEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of JEN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.19
EPS Next 2Y3.11%
EPS Next 3Y6.91%

3

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.90%.
Compared to an average industry Dividend Yield of 2.86, JEN pays a bit more dividend than its industry peers.
JEN's Dividend Yield is slightly below the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.9%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years0
JEN.DE Yearly Dividends per shareJEN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

JEN pays out 28.10% of its income as dividend. This is a sustainable payout ratio.
DP28.1%
EPS Next 2Y3.11%
EPS Next 3Y6.91%
JEN.DE Yearly Income VS Free CF VS DividendJEN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
JEN.DE Dividend Payout.JEN.DE Dividend Payout, showing the Payout Ratio.JEN.DE Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

FRA:JEN (10/14/2025, 5:35:30 PM)

19.31

-0.41 (-2.08%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners40.82%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.11B
Analysts83.75
Price Target24.64 (27.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.9%
Yearly Dividend0.35
Dividend Growth(5Y)0%
DP28.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.43%
Min EPS beat(2)-20.99%
Max EPS beat(2)-5.88%
EPS beat(4)2
Avg EPS beat(4)-2.09%
Min EPS beat(4)-20.99%
Max EPS beat(4)13.86%
EPS beat(8)3
Avg EPS beat(8)-6.27%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.06%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)-2.79%
Revenue beat(4)0
Avg Revenue beat(4)-2.77%
Min Revenue beat(4)-3.34%
Max Revenue beat(4)-1.93%
Revenue beat(8)1
Avg Revenue beat(8)-6.15%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.87%
PT rev (3m)-5.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.79%
EPS NY rev (1m)0.44%
EPS NY rev (3m)-20.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.51%
Valuation
Industry RankSector Rank
PE 14.3
Fwd PE 11.21
P/S 1.03
P/FCF 16.05
P/OCF 6.75
P/B 1.15
P/tB 3.96
EV/EBITDA 7.57
EPS(TTM)1.35
EY6.99%
EPS(NY)1.72
Fwd EY8.92%
FCF(TTM)1.2
FCFY6.23%
OCF(TTM)2.86
OCFY14.83%
SpS18.75
BVpS16.74
TBVpS4.87
PEG (NY)N/A
PEG (5Y)2.19
Profitability
Industry RankSector Rank
ROA 4.67%
ROE 8.08%
ROCE 9.24%
ROIC 6.34%
ROICexc 6.61%
ROICexgc 14.19%
OM 11.41%
PM (TTM) 7.21%
GM 32.28%
FCFM 6.42%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
ROICexc(3y)7.54%
ROICexc(5y)6.96%
ROICexgc(3y)16.1%
ROICexgc(5y)15.71%
ROCE(3y)10.41%
ROCE(5y)9.58%
ROICexcg growth 3Y-2.02%
ROICexcg growth 5Y2.07%
ROICexc growth 3Y7.18%
ROICexc growth 5Y-3.9%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 6.46
Debt/EBITDA 1.6
Cap/Depr 124.4%
Cap/Sales 8.85%
Interest Coverage 7.67
Cash Conversion 82.4%
Profit Quality 88.97%
Current Ratio 1.62
Quick Ratio 0.8
Altman-Z 2.53
F-Score4
WACC5.81%
ROIC/WACC1.09
Cap/Depr(3y)121.37%
Cap/Depr(5y)106.88%
Cap/Sales(3y)8.22%
Cap/Sales(5y)7.57%
Profit Quality(3y)101.44%
Profit Quality(5y)95.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.57%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-38.1%
EPS Next Y-16.22%
EPS Next 2Y3.11%
EPS Next 3Y6.91%
EPS Next 5Y9.69%
Revenue 1Y (TTM)-2.59%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-10.49%
Revenue Next Year-4.34%
Revenue Next 2Y0.79%
Revenue Next 3Y2.53%
Revenue Next 5Y3.76%
EBIT growth 1Y-10.03%
EBIT growth 3Y11.91%
EBIT growth 5Y11.51%
EBIT Next Year35%
EBIT Next 3Y20.01%
EBIT Next 5Y14.54%
FCF growth 1Y-0.61%
FCF growth 3Y12.68%
FCF growth 5Y2.87%
OCF growth 1Y7.73%
OCF growth 3Y19.51%
OCF growth 5Y8.88%